Dr. J. Luke Engeriser attended medical school at Northwestern University and completed psychiatry residency training at Tripler Army Medical Center in Honolulu. Dr. Engeriser served an additional three years in the Army at Fort Benning, Georgia, where he held the position of Chief, Department of Behavioral Health. After separating from the Army, Dr. Engeriser was Medical Director of Mid-Coast Mental Health Center/PenBay Psychiatry in Rockland, Maine. Prior to attending medical school, he completed a Master of Arts in Divinity at the University of Chicago and worked as a teacher of English at the Teacher Training College in Torun, Poland. Dr. Engeriser is a Past President of the Alabama Psychiatric Physicians Association, and he is currently President of the Alabama Society of Addiction Medicine. He is a Distinguished Fellow of the American Psychiatric Association and American Society of Addiction Medicine. He is currently the Deputy Chief Medical Officer for AltaPointe Health and is the Program Director for the Psychiatry Residency and Addiction Medicine Fellowship at the University of South Alabama.

Lindsey Hohmann, Pharm.D., Ph.D., joined the Harrison School of Pharmacy as an assistant professor in the Department of Pharmacy Practice on October 1, 2019. In her role, she will promote clinical and translational science research within the school. Dr. Hohmann’s research interests include implementation science and mixed methods, substance misuse prevention, and implementation of innovations in community-based healthcare organizations. After earning a bachelor’s degree in cell and developmental biology from the University of California at Santa Barbara in 2008, Dr. Hohmann went on to complete her Pharm.D. at the University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences in 2012. After spending several years in practice, Dr. Hohmann came to Auburn, completing her Ph.D. in pharmaceutical sciences from the Harrison School of Pharmacy in 2019. While at HSOP, she studied in the Health Outcomes Research and Policy option. Her doctoral dissertation, “Empowering community pharmacists to prevent opioid overdose deaths: development and implementation of a targeted naloxone training program,” focused on enhancing naloxone services implementation in community pharmacies in Alabama. The study was funded by Auburn University departmental support and grant number R36HS026669 from the Agency for Healthcare Research and Quality (AHRQ). Dr. Hohmann is a Medication Therapy Management (MTM) certified pharmacist. She is also active within the American Pharmacists Association (APhA), American Association of Colleges of Pharmacy (AACP), and International Society for Pharmacoeconomics and Outcomes Research (ISPOR).